The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
HB

h.brandt

TL2 Moderator · Bergen

Contributes reviews on supplier material. Based in Bergen.

Joined 15 May 2025 · last posted 6d

78Posts here
4Topics
1Solutions
1.2kLikes received
1.2kLikes given
25Badges
215Days visited
5.2kPosts read

Recent activity

Full stream
  • Splitting an overlong document into two Replied, post #34 · Documentation › Wiki requests · 22 Jul 2026 · 0 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
  • Journal club: what we got wrong in an earlier session Replied, post #88 · Evidence › Journal club · 16 Jul 2026 · 5 likes Worth separating two things that post #84 runs together. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not…
  • 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #106 · Devices › Syringes & needles · 14 Jul 2026 · 1 like Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
  • Why chargeback is not the safety net people assume Replied, post #23 · Sourcing › Payments · 6 Jul 2026 · 1 like No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
  • How shortages have affected compounding permissions Replied, post #11 · Access › Shortages · 2 Jul 2026 · 17 likes post #10 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
  • Reading order for a first week here, and what to skip until later — what changed since Started this topic · Start Here › Welcome · 29 Jun 2026 · 0 likes Reading order for a first week here, and what to skip until later — what changed since Writing it up because I had to work it out twice and would rather nobody else…
  • Prescription requirements and telehealth models — a second dataset Replied, post #82 · Sourcing › Regulatory · 27 Jun 2026 · 10 likes Coming back to post #80, because the follow-up matters more than the original answer. Approval versus licensing: a compound can be approved for a specific indication in…
  • About the Receptor biology category Replied, post #7 · Pharmacology › Receptor biology · 27 Jun 2026 · 28 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
  • Submitting a sample: the process end to end Replied, post #40 · Sourcing › Independent verification · 26 Jun 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
  • Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #43 · Compounds › Repair & healing peptides · 16 Jun 2026 · 8 likes Picking up post #40: that is the part I would want checked first. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
  • Naming conventions for research peptides and the confusion they cause Replied, post #14 · Compounds › Other compounds · 11 Jun 2026 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
  • Reading a trial's population section before its results Replied, post #82 · Evidence › Trials · 3 Jun 2026 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…